Diptoindonesin G, a new Hsp90 drug

Diptoindonesin G is a middle domain HSP90 modulator for cancer treatment

(2022) Kristine Donahue et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Old and New Approaches to Target the Hsp90 Chaperone

(2019) Jackee Sanchez et al.   CURRENT CANCER DRUG TARGETS

Discovery of new molecular entities able to strongly interfere with Hsp90 C-terminal domain

(2018) Stefania Terracciano et al.   Scientific Reports

The HSP90 chaperone machinery

(2017) Florian H. Schopf et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Reciprocal Regulation of ERα and ERβ Stability and Activity by Diptoindonesin G

(2015) Zibo Zhao et al.   CHEMISTRY & BIOLOGY

Hsp90: Breaking the Symmetry

(2015) Matthias P. Mayer et al.   MOLECULAR CELL